{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:14:14Z","timestamp":1772165654858,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T00:00:00Z","timestamp":1606694400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T00:00:00Z","timestamp":1606694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Science and Technology Project of Guangdong Province","award":["2019A1515010206"],"award-info":[{"award-number":["2019A1515010206"]}]},{"DOI":"10.13039\/501100018609","name":"High-level Hospital Construction Project of Guangdong Provincial People's Hospital","doi-asserted-by":"crossref","award":["DFJH202002"],"award-info":[{"award-number":["DFJH202002"]}],"id":[{"id":"10.13039\/501100018609","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science and Technology Program of Guangzhou, China","award":["202002030094"],"award-info":[{"award-number":["202002030094"]}]},{"name":"Outstanding Young Medical Talents in Guangdong Province","award":["KJ012019435"],"award-info":[{"award-number":["KJ012019435"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>COVID-19 has become a major global threat. The present study aimed to develop a nomogram model to predict the survival of COVID-19 patients based on their clinical and laboratory data at admission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      COVID-19 patients who were admitted at Hankou Hospital and Huoshenshan Hospital in Wuhan, China from January 12, 2020 to March 20, 2020, whose outcome during the hospitalization was known, were retrospectively reviewed. The categorical variables were compared using Pearson\u2019s \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      -test or Fisher\u2019s exact test, and continuous variables were analyzed using Student\u2019s\n                      <jats:italic>t<\/jats:italic>\n                      -test or Mann Whitney\n                      <jats:italic>U<\/jats:italic>\n                      -test, as appropriate. Then, variables with a\n                      <jats:italic>P-<\/jats:italic>\n                      value of \u22640.1 were included in the log-binomial model, and merely these independent risk factors were used to establish the nomogram model. The discrimination of the nomogram was evaluated using the area under the receiver operating characteristic curve (AUC), and internally verified using the Bootstrap method.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 262 patients (134 surviving and 128 non-surviving patients) were included in the analysis. Seven variables, which included age (relative risk [RR]: 0.905, 95% confidence interval [CI]: 0.868\u20130.944;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), chronic heart disease (CHD, RR: 0.045, 95% CI: 0.0097\u20130.205;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001, the percentage of lymphocytes (Lym%, RR: 1.125, 95% CI: 1.041\u20131.216;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0029), platelets (RR: 1.008, 95% CI: 1.003\u20131.012;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001), C-reaction protein (RR: 0.982, 95% CI: 0.973\u20130.991;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), lactate dehydrogenase (LDH, RR: 0.993, 95% CI: 0.990\u20130.997;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) and D-dimer (RR: 0.734, 95% CI: 0.617\u20130.879;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), were identified as the independent risk factors. The nomogram model based on these factors exhibited a good discrimination, with an AUC of 0.948 (95% CI: 0.923\u20130.973).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A nomogram based on age, CHD, Lym%, platelets, C-reaction protein, LDH and D-dimer was established to accurately predict the prognosis of COVID-19 patients. This can be used as an alerting tool for clinicians to take early intervention measures, when necessary.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-05614-2","type":"journal-article","created":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T08:02:52Z","timestamp":1606723372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["A nomogramic model based on clinical and laboratory parameters at admission for predicting the survival of COVID-19 patients"],"prefix":"10.1186","volume":"20","author":[{"given":"Xiaojun","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huifang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junwei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuqi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weifeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengbin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinglin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,30]]},"reference":[{"issue":"7","key":"5614_CR1","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1002\/jmv.25885","volume":"92","author":"A Hoseinpour Dehkordi","year":"2020","unstructured":"Hoseinpour Dehkordi A, Alizadeh M, Derakhshan P, Babazadeh P, Jahandideh A. Understanding epidemic data and statistics: a case study of COVID-19. J Med Virol. 2020;92(7):868\u201382.","journal-title":"J Med Virol"},{"issue":"3","key":"5614_CR2","first-page":"e7351","volume":"12","author":"HK Onyeaka","year":"2020","unstructured":"Onyeaka HK, Zahid S, Patel RS. The unaddressed behavioral health aspect during the coronavirus pandemic. Cureus. 2020;12(3):e7351.","journal-title":"Cureus"},{"key":"5614_CR3","doi-asserted-by":"publisher","unstructured":"Sun T, Weng D. Estimating the effects of asymptomatic and imported patients on COVID-19 epidemic using mathematical modeling. J Med Virol. 2020. https:\/\/doi.org\/10.1002\/jmv.25939.","DOI":"10.1002\/jmv.25939"},{"issue":"2","key":"5614_CR4","doi-asserted-by":"publisher","first-page":"e18810","DOI":"10.2196\/18810","volume":"6","author":"R Ohannessian","year":"2020","unstructured":"Ohannessian R, Duong TA, Odone A. Global telemedicine implementation and integration within health systems to fight the COVID-19 pandemic: a call to action. JMIR Public Health Surveill. 2020;6(2):e18810.","journal-title":"JMIR Public Health Surveill"},{"issue":"4","key":"5614_CR5","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1086\/380973","volume":"38","author":"Z Zou","year":"2004","unstructured":"Zou Z, Yang Y, Chen J, Xin S, Zhang W, Zhou X, Mao Y, Hu L, Liu D, Chang B, et al. Prognostic factors for severe acute respiratory syndrome: a clinical analysis of 165 cases. Clin Infect Dis. 2004;38(4):483\u20139.","journal-title":"Clin Infect Dis"},{"key":"5614_CR6","first-page":"5864","volume":"25","author":"Y Xiao","year":"2019","unstructured":"Xiao Y, Fu X, Wang Y, Wu Y, Wang W, Zhang Q. Development and validation of risk Nomogram model predicting coronary microvascular obstruction in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous catheterization. Sci Rep. 2019;25:5864\u201377.","journal-title":"Sci Rep"},{"issue":"18","key":"5614_CR7","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1200\/JCO.2015.65.9128","volume":"34","author":"YQ Huang","year":"2016","unstructured":"Huang YQ, Liang CH, He L, Tian J, Liang CS, Chen X, Ma ZL, Liu ZY. Development and validation of a Radiomics Nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol. 2016;34(18):2157\u201364.","journal-title":"J Clin Oncol"},{"key":"5614_CR8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2147\/RMHP.S242168","volume":"13","author":"Q Cheng","year":"2020","unstructured":"Cheng Q, Sun Z, Zhao G, Xie L. Nomogram for the individualized prediction of survival among patients with H7N9 infection. Risk Manag Healthc Policy. 2020;13:255\u201369.","journal-title":"Risk Manag Healthc Policy"},{"key":"5614_CR9","first-page":"E011","volume":"49","author":"YQ Ding","year":"2020","unstructured":"Ding YQ, Bian XW. Interpretation of pathological changes for \u201cGuidelines for the Diagnosis and Treatment of COVID-19 by the National Health Commission (Trial Version 7)\u201d. Zhonghua Bing Li Xue Za Zhi. 2020;49:E011.","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"5614_CR10","volume-title":"Diagnosis and treatment scheme for COVID-19 (5th edition, China) (in Chinese)","author":"National Health Commission of the People\u2019s Republic of China","year":"2020","unstructured":"National Health Commission of the People\u2019s Republic of China. Diagnosis and treatment scheme for COVID-19 (5th edition, China) (in Chinese). 2020."},{"issue":"10229","key":"5614_CR11","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u201362.","journal-title":"Lancet"},{"issue":"3","key":"5614_CR12","doi-asserted-by":"publisher","first-page":"e033026","DOI":"10.1136\/bmjopen-2019-033026","volume":"10","author":"WM Jang","year":"2020","unstructured":"Jang WM, Kim UN, Jang DH, Jung H, Cho S, Eun SJ, Lee JY. Influence of trust on two different risk perceptions as an affective and cognitive dimension during Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea: serial cross-sectional surveys. BMJ Open. 2020;10(3):e033026.","journal-title":"BMJ Open"},{"issue":"5","key":"5614_CR13","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","volume":"8","author":"X Yang","year":"2020","unstructured":"Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475\u201381.","journal-title":"Lancet Respir Med"},{"issue":"11","key":"5614_CR14","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061\u20139.","journal-title":"JAMA"},{"issue":"4","key":"5614_CR15","first-page":"304","volume":"130","author":"G Lippi","year":"2020","unstructured":"Lippi G, Wong J, Henry BM. Hypertension and its severity or mortality in coronavirus disease 2019 (COVID-19): a pooled analysis. Pol Arch Intern Med. 2020;130(4):304\u201330.","journal-title":"Pol Arch Intern Med"},{"key":"5614_CR16","first-page":"104371","volume":"127","author":"H Ren","year":"2020","unstructured":"Ren H, Wang Q, Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, Ji R, Wang H, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. J Med Virol. 2020;127:104371.","journal-title":"J Med Virol"},{"key":"5614_CR17","doi-asserted-by":"publisher","unstructured":"Kumar V, Dhanjal JK, Bhargava P, Kaul A, Wang J, Zhang H, Kaul SC, Wadhwa R, Sundar D. Withanone and Withaferin-a are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells. J Biomol Struct Dyn. 2020:1\u201313. https:\/\/doi.org\/10.1080\/07391102.2020.1775704.","DOI":"10.1080\/07391102.2020.1775704"},{"issue":"10","key":"5614_CR18","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.3390\/molecules25102271","volume":"25","author":"N Rahman","year":"2020","unstructured":"Rahman N, Basharat Z, Yousuf M, Castaldo G, Rastrelli L, Khan H. Virtual Screening of Natural Products against Type II Transmembrane Serine Protease (TMPRSS2), the Priming Agent of Coronavirus 2 (SARS-CoV-2). Molecules. 2020;25(10):2271.","journal-title":"Molecules"},{"key":"5614_CR19","doi-asserted-by":"publisher","unstructured":"Wu C, Ye D, Mullick AE, Li Z, Danser AHJ, Daugherty A, Lu HS. Effects of Renin-Angiotensin Inhibition on ACE2 and TMPRSS2 Expression: Insights into COVID-19. bioRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.06.08.137331.","DOI":"10.1101\/2020.06.08.137331"},{"issue":"2","key":"5614_CR20","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):271\u2013280.e278.","journal-title":"Cell"},{"issue":"9","key":"5614_CR21","doi-asserted-by":"publisher","first-page":"e202000786","DOI":"10.26508\/lsa.202000786","volume":"3","author":"D Bestle","year":"2020","unstructured":"Bestle D, Heindl MR, Limburg H, van Van Lam T, Pilgram O, Moulton H, Stein DA, Hardes K, Eickmann M, Dolnik O, et al. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells. Life Sci Alliance. 2020;3(9):e202000786.","journal-title":"Life Sci Alliance"},{"issue":"7","key":"5614_CR22","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s41440-020-0455-8","volume":"43","author":"H Kai","year":"2020","unstructured":"Kai H, Kai M. Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19. Hypertens Res. 2020;43(7):648\u201354.","journal-title":"Hypertens Res"},{"issue":"4","key":"5614_CR23","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.dsx.2020.04.020","volume":"14","author":"I Astuti","year":"2020","unstructured":"Astuti I, Ysrafil. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): an overview of viral structure and host response. Diabetes Metab Syndr. 2020;14(4):407\u201312.","journal-title":"Diabetes Metab Syndr"},{"issue":"4","key":"5614_CR24","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/joim.13101","volume":"288","author":"A Aleksova","year":"2020","unstructured":"Aleksova A, Ferro F, Gagno G, Cappelletto C, Santon D, Rossi M, Ippolito G, Zumla A, Beltrami AP, Sinagra G. COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - is there any scientific evidence for controversy? J Intern Med. 2020;288(4):410\u201321.","journal-title":"J Intern Med"},{"issue":"5","key":"5614_CR25","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.immuni.2020.04.003","volume":"52","author":"T Hirano","year":"2020","unstructured":"Hirano T, Murakami M. COVID-19: a new virus, but a familiar receptor and cytokine release syndrome. Immunity. 2020;52(5):731\u20133.","journal-title":"Immunity"},{"issue":"7","key":"5614_CR26","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.ajem.2020.04.048","volume":"38","author":"B Long","year":"2020","unstructured":"Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am J Emerg Med. 2020;38(7):1504\u20137.","journal-title":"Am J Emerg Med"},{"issue":"5","key":"5614_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11886-020-01292-3","volume":"22","author":"H Zhu","year":"2020","unstructured":"Zhu H, Rhee JW, Cheng P, Waliany S, Chang A, Witteles RM, Maecker H, Davis MM, Nguyen PK, Wu SM. Cardiovascular complications in patients with COVID-19: consequences of viral toxicities and host immune response. Curr Cardiol Rep. 2020;22(5):32.","journal-title":"Curr Cardiol Rep"},{"key":"5614_CR28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cca.2020.03.022","volume":"506","author":"G Lippi","year":"2020","unstructured":"Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta. 2020;506:145\u20138.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"5614_CR29","first-page":"16","volume":"36","author":"HJ Wang","year":"2020","unstructured":"Wang HJ, Du SH, Yue X, Chen CX. Review and Prospect of pathological features of Corona virus disease. Fa yi xue za zhi. 2020;36(1):16\u201320.","journal-title":"Fa yi xue za zhi"},{"issue":"4","key":"5614_CR30","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3345\/cep.2020.00493","volume":"63","author":"SE Park","year":"2020","unstructured":"Park SE. Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; coronavirus Disease-19). Clin Exp Pediatr. 2020;63(4):119\u201324.","journal-title":"Clin Exp Pediatr"},{"key":"5614_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25770","volume-title":"Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19","author":"Y Gao","year":"2020","unstructured":"Gao Y, Li T, Han M, Li X, Wu D, Xu Y, Zhu Y, Liu Y, Wang X, Wang L. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19; 2020."},{"key":"5614_CR32","volume-title":"Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19","author":"R Qu","year":"2020","unstructured":"Qu R, Ling Y, Zhang YH, Wei LY, Chen X, Li XM, Liu XY, Liu HM, Guo Z. Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19; 2020."},{"issue":"3","key":"5614_CR33","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1152\/physrev.00013.2020","volume":"100","author":"HL Ji","year":"2020","unstructured":"Ji HL, Zhao R, Matalon S, Matthay MA. Elevated plasmin (ogen) as a common risk factor for COVID-19 susceptibility. Physiol Rev. 2020;100(3):1065\u201375.","journal-title":"Physiol Rev"},{"key":"5614_CR34","doi-asserted-by":"crossref","unstructured":"Zhang Y, He L, Chen H, Lu S, Xiong Y, Liu J, Zheng Y, Wang S, Liu L. Manifestations of blood coagulation and its relation to clinical outcomes in severe COVID-19 patients: retrospective analysis. Int J Lab Hematol. 2020;42:766\u201372.","DOI":"10.1111\/ijlh.13273"},{"issue":"9","key":"5614_CR35","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1111\/liv.14455","volume":"40","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q. Liver impairment in COVID-19 patients: a retrospective analysis of 115 cases from a single center in Wuhan city, China. Liver Int. 2020;40(9):2095\u2013103.","journal-title":"Liver Int"},{"key":"5614_CR36","doi-asserted-by":"publisher","unstructured":"Yang F, Shi S, Zhu J, Shi J, Dai K, Chen X. Analysis of 92 deceased patients with COVID-19. J Med Virol. 2020. https:\/\/doi.org\/10.1002\/jmv.25891.","DOI":"10.1002\/jmv.25891"},{"issue":"1","key":"5614_CR37","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jaci.2020.04.006","volume":"146","author":"X Li","year":"2020","unstructured":"Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, Shi J, Zhou M, Wu B, Yang Z, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110\u20138.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"5614_CR38","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology \u2013 more than meets the eye. Lancet Oncology. 2015;16(4):e173\u201380.","journal-title":"Lancet Oncology"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05614-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-05614-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05614-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T08:09:04Z","timestamp":1606723744000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05614-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,30]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5614"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05614-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-34708\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-34708\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-34708\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-34708\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,30]]},"assertion":[{"value":"2 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Hankou Hospital in Wuhan (HKYY-2020-028), and granted the study an exemption from informed consent due to its retrospective nature. The data used in this study was anonymised before its use.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"899"}}